T. Kiss, J. Costa Pessoa et al.
FULL PAPER
2 H, CH2CH3), 4.52Ϫ4.60 (m, 1 H, αCH Ala), 5.13 (s, 2 H,
Amino acid or salicylic acid incorporation was monitored using
CH2Ar), 5.57 (br. s, 1 H, NH), 6.71 (br. s, 1 H, NH), 7.36Ϫ7.33 the ninhydrin test. The completed peptide resins were treated with
(m, 5 H, Ar) ppm.
TFA/dichloromethane/water (35:60:5, vol/vol), at 0 °C for 1 h. The
solvents were removed and the resultant free product was dissolved
in 10% aqueous acetic acid, filtered and lyophilised (798 mg). The
crude peptide derivative (100 mg) was purified by reverse-phase
HPLC using a Nucleosil 7C-18 column (16 ϫ 250 mm). The sol-
vent system used was the following: 0.1% TFA in water, 0.1% TFA,
80% acetonitrile in water, gradient: 0% Ǟ 0% B over 10 min, then
10% Ǟ 30% over 50 min, flow 3.5 mL/min, detection at 226 nm.
The appropriate fractions were combined and lyophilised. Peptide
purity was above 97% (HPLC) and the measured Mw (227) value
was in good agreement with the calculated one. NMR (D2O): δ ϭ
1.38 (d, J ϭ 7.2 Hz, 9 Hz, 3 H, CH3 Ala), 4.11 (s, 2 H, CH2 Gly),
4.34 (m, 1 H, αCH Ala), 6.99 (tap, J ϭ 7.8 Hz, 2 H, 3-H and 5-
H), 7.46 (tap, J ϭ 7.8 Hz, 1 H, 4-H) 7.50 (dd, J ϭ 1.5 Hz, 2 and
9.46 Hz, 1 H, 6-H) ppm.
HGly- -AlaOEt·HBr: Z-Gly--AlaOEt (3.08 g, 10 mmol) was
L
treated with 40% HBr/acetic acid (15 mL) at room temperature for
1 h with occasional stirring and protection from moisture. Diethyl
ether was added and after cooling for a few hours the precipitated
solid was filtered, washed with diethyl ether and dried. The chrom-
atographically pure compound was used in the next step without
further purification. Yield (2.42 g, 94%). NMR ([D6]DMSO): δ ϭ
1.20 (t, J ϭ 7.2 Hz, 3 H, CH2CH3), 1.30 (d, J ϭ 7.2 Hz, 3 H, CH3
Ala), 3.57 (d, J ϭ 3.3 Hz, 2 H, CH2 Gly), 4.10 (q, J ϭ 7.2 Hz, 2
H, CH2CH3), 4.23Ϫ4.32 (m, 1 H, αCH Ala), 8.01 (br. s, 3 H,
NH3ϩ), 8.70 (d, J ϭ 7.2 Hz, 1 H, NH Ala) ppm.
HSalGly-L-AlaOEt: Salicylic acid (0.69 g, 5 mmol) was dissolved
in ethyl acetate (20 mL) and the solution cooled to 0 °C. DCC
(1.08 g, 5.2 mmol), HGlyAla·OEt·HBr (1.28 g, 5 mmol) and tri-
ethylamine (0.9 mL, 5 mmol) were then added successively. The
reaction mixture was stirred at room temperature overnight. The
insoluble material was filtered off and the solvents removed under
reduced pressure. The residue was dissolved in a minimum amount
of acetone and stored at 0 °C for 4 h. The precipitated solid was
filtered off (dicyclohexylurea) and the solution concentrated. The
oil obtained was crystallized from ethyl acetate/petroleum ether.
(0.808 g, first crop, 55%, m.p. 104Ϫ106 °C). NMR ([D6]DMSO):
δ ϭ 1.28 (d, J ϭ 7.5 Hz, 3 H, CH3 Ala), 1.17 (t, J ϭ 7.2 Hz, 3 H,
CH2CH3), 4.07 (q, J ϭ 7.2 Hz, 2 H, CH2CH3), 3.94 (m, 2 H, CH2
Gly), 4.20 (m, 1 H, αCH Ala), 6.91 (tap, J ϭ 7.8 Hz, 2 H, 3-H and
5-H), 7.40 (tap, J ϭ 8 Hz, 1 H, 4-H) 7.86 (dd, J ϭ 1.2 Hz and
8 Hz,1 H, 6-H), 8.46,(d, J ϭ 8.4 Hz, 1 H, NH Ala), 9.04 (t, J ϭ
6 Hz, 1 H, NH Gly), 12.25 (br. s, 1 H, OH) ppm. C14H18N2O5
(294.3): calcd. C 57.14, H 6.16, N 9.52; found C 57.6, H 6.1, N 9.7.
Synthesis of the Complexes
VO(SalGly-L-Ala)·3.2H2O·0.2EtOH (2): To
a
solution of
H2SalGly--Ala (1 mmol) and sodium acetateϪtrihydrate (2 mmol)
in ethanol/water (2.5:5 mL) was slowly added a solution of
VOSO4·5H2O (1 mmol) in water (1 mL). The mixture was divided
in two equal parts (A and B). The pH of solution A was adjusted
to 5.5. A blue-green solid precipitated which was collected by fil-
tration and washed with ethanol/water (1:2), diethyl ether
and dried. Yield: 40% (80 mg). C12H12N2O6V·3.2H2O·
0.2EtOH: calcd. C 37.42, H 4.86, N 7.04; found C 37.4, H 5.3,
N 7.00.
K[Cu(SalGly-L-Ala)]·3.2H2O (3): To a solution of H2SalGly--
Ala (0.5 mmol) and KOH (0.5 mmol) in water (10 mL), was slowly
added Cu(CH3COO)2·H2O (0.5 mmol) in ethanol (5 mL). The pH
was adjusted to 6 with 2 KOH and kept at ഠ 45 °C for 1 h. A
green precipitate was collected by filtration, washed with ethanol/
water (1:2), ethanol and diethyl ether and dried. Yield: 42% (90
mg). C12H11CuKN2O5·3.2H2O: calcd. C 34.03, H 4.14, N 6.61;
found C 33.7, H 3.7, N 6.2.
H2Sal-L-GlyAla (1): HSalGly--AlaOEt (0.734 g, 2.5 mmol) was
dissolved in methanol (5 mL) and 1 NaOH (5.5 mL, 5.5 mmol)
was added. The mixture was stirred at room temperature for 4 h
and 1 HCl (2.5 mL, 2.5 mmol) was then added. The methanol
was removed under reduced pressure and the solution thus ob-
tained cooled in an ice bath and acidified with 1 HCl (3 mL)
with vigorous stirring. The white solid precipitated was filtered off,
washed with water and dried (0.581 g, 87%), m.p. 197Ϫ199 °C.
NMR ([D6]DMSO): δ ϭ 1.28 (d, J ϭ 7.5 Hz, 3 H, CH3 Ala), 3.94
(m, 2 H, CH2 Gly), 4.20 (m, 1 H, αCH Ala), 6.91 (tap, J ϭ 7.8 Hz,
2 H, 3-H and 5-H), 7.39 (tap, J ϭ 7.8 Hz, 1 H, 4-H) 7.86 (dd, J ϭ
1.2 Hz and 8 Hz, 1 H, 6-H), 8.34 (d, J ϭ 7.5 Hz, 1 H, NH Ala),
9.03 (t, J ϭ 6 Hz, 1 H, NH Gly), 12.20(s, 1 H, OH), 12.40 (br. s, 1
H, OH) ppm. C12H14N2O5 (266.3): calcd. C 54.13, H 5.30, N 10.52;
found C 54.17, H 5.41, N 10.42.
Physical and Spectroscopic Studies
Melting points were recorded by using a Gallenkamp melting
point apparatus and are uncorrected. NMR spectroscopic data
were recorded either with a Varian Unity Plus 300 Spectrometer
(for the several steps of the synthesis of 1) in the solvent indicated,
or with a Varian Unity-500 Spectrometer operating at frequencies
of 131.404 MHz and 499.824 MHz, respectively, using a 5-mm
broad-band probe at 25.0Ϯ0.5 °C. 51V NMR chemical shifts were
referenced to an external VOCl3 solution at δ ϭ 0 ppm. The 51V
NMR acquisition parameters were as follows: 33 kHz spectral
width, 30-µs pulse width, 1 s acquisition time and 10 Hz line broad-
ening. IR spectra were recorded with a BioRad FTS-3000 MX
FTIR spectrometer. CD spectra were recorded with a JASCO-720
spectropolarimeter with a red-sensitive photomultiplier (EXWL-
308). Visible spectra were recorded with a Hitachi U-2000 spectro-
photometer. X-band (9.44 GHz) EPR spectra were usually re-
corded at 77 K (on glasses made by freezing solutions in liquid
nitrogen) with a Bruker ESP 300E X-band spectrometer. Mass
spectra were recorded with a Finnigan TSQ-7000 tandem quadru-
pole mass spectrometer equipped with an electrospray ion source.
The HPLC apparatus was made by Knauer (Berlin, Germany).
Route 2
The dipeptide chain was elongated on an HMP resin (1.1 mmol/g).
In the first step, Fmoc-AlaϪOH (5.47, 17.6 mmol) was coupled to
the resin (4 g, 4.4 mmol) in the presence of HOBt (2.38 g,
17.6 mmol), DCC (3.63 g, 17.6 mmol) and dimethylaminopyridine
(1.07 g, 8.8 mmol). After removing the Fmoc protecting group by
treatment with piperidine, the resultant free amino function was
acylated with FmocϪGlyϪOH (2.97 g, 10 mmol). After com-
pletion of the dipeptide unit, the N-terminal Fmoc-protecting
group was removed as previously described and the resultant pri-
mary amino group was acylated with salicylic acid (2.76 g,
20 mmol). The phenolic hydroxy group of the salicylic acid residue
was unprotected. All the couplings were performed with N,NЈ-di-
cyclohexylcarbodiimide in the presence of 1-hydroxybenzotriazole.
All samples for the pH-potentiometric and spectrophotometric
measurements were prepared under inert conditions (under high
purity nitrogen or argon). For potentiometric measurements the
2120
2003 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Inorg. Chem. 2003, 2113Ϫ2122